Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma

Published:2007-07 Issue:6 Volume:18 Page:703-708
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lin Chia-Chi,Yeh Kun-Huei,Yang Chih-Hsin,Hsu Chiun,Tsai Yu-Chieh,Hsu Wei-Ling,Cheng Ann-Lii,Hsu Chih-Hung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference22 articles.

1. Treatment of metastatic esophagus and gastric cancer;Shah;Semin Oncol,2004

2. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus;Ajani;J Natl Cancer Inst,1994

3. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus;Ilson;J Clin Oncol,1998

4. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer;Perez;J Clin Oncol,2001

5. CALGB 9840: phase III study of weekly (W) paclitaxel (P) via 1-hour (h) infusion versus standard (S) 3 h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC;Seidman;J Clin Oncol,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma;Cancer Medicine;2022-04-17

2. Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial;Journal of Clinical Oncology;2019-07-10

3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS;Annals of Oncology;2019-01

4. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol;Radiation Oncology;2018-02-27

5. Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: A meta-analysis;Cancer Treatment Reviews;2012-10